TRAP5b and RANKL/OPG Predict Bone Pathology in Patients with Gaucher Disease
Background and objective: Bone involvement occurs in 75% of patients with Gaucher disease (GD), and comprises structural changes, debilitating pain, and bone density abnormalities. Osteoporosis is a silent manifestation of GD until a pathologic fracture occurs. Thus, early diagnosis is crucial for i...
Main Authors: | Margarita Ivanova, Julia Dao, Lauren Noll, Jacqueline Fikry, Ozlem Goker-Alpan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/10/2217 |
Similar Items
-
Baicalin Ameliorates Dexamethasone-Induced Osteoporosis by Regulation of the RANK/RANKL/OPG Signaling Pathway
by: Zhao Y, et al.
Published: (2020-01-01) -
The effect of Phase 1 periodontal treatment on the salivary RANKL/OPG ratio in severe chronic periodontitis
by: Ansari Moghadam S, et al.
Published: (2019-08-01) -
Association between low bone mass and the serum RANKL and OPG in patients with nephrolithiasis
by: Asieh Mansour, et al.
Published: (2018-07-01) -
Wnt signaling pathway inhibitors, sclerostin and DKK-1, correlate with pain and bone pathology in patients with Gaucher disease
by: Margarita M. Ivanova, et al.
Published: (2022-11-01) -
Diosmin mitigates dexamethasone-induced osteoporosis in vivo: Role of Runx2, RANKL/OPG, and oxidative stress
by: El-Shaimaa A. Arafa, et al.
Published: (2023-05-01)